Max Payne and Alan Wake developer Remedy is making preparations to becoming a publicly traded company, stating their intent to double down on multiple projects simultaneously. The Finland-based development house states that they are estimating to be listed on the First North Finland market by May 2017.
We’re developing our business in line with our strategy towards a multi-project model, which helps us release high-quality games to the global market more often. Our goal is to be one of most renowned game companies in the world.
Remedy CEO Tero Virtala
The company becoming listed on the market means that they may experience a dramatic financial growth once their listing is complete, securing ownership of the company’s many popular properties.
In the press release posted on Remedy’s website, Virtala reflects on the company’s successes in 2016, which saw the release of the TV/gaming hybrid Quantum Break in early last year.
Our revenue grew 19.4%, being €16.4M. Our operating profit was €3.9M. The excellent financial developments were driven by the release of Quantum Break in spring 2016 and the profits from our game portfolio and projects in development.
The profit generated will help reimagine the Remedy studio from a one project at a time structure to one where the company will be able to develop multiple games in tandem. This will hopefully allow Remedy to release more games in less time, increasing the revenue stream as well as satiating the part of their fanbase that has been clamoring for more sequels to some of the company’s intellectual property.
Remedy is currently working on CrossFire, a franchise that has since gone on to cement its permanent place in the lexicon of video games as one of the most popular games ever to be released in China. It still manages to do really well, making CrossFire the most popular first-person shooter game in the world.
What do you think of Remedy’s listing in the market? What game would you want them to develop next? Let us know in the comment section down below!